The role of caveolin-1 in human breast cancer Neill PataniLesley-Ann MartinMitch Dowsett Review 08 September 2011 Pages: 1 - 15
Leptin and leptin receptor genes in relation to premenopausal breast cancer incidence and grade in Caucasian women Fangyi GuPeter KraftKarin B. Michels Review 25 September 2011 Pages: 17 - 25
The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk Ke-Da YuAo-Xiang ChenZhi-Ming Shao Preclinical study 25 August 2010 Pages: 27 - 31
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer Carina StrandCecilia AhlinMårten Fernö Preclinical study 18 February 2011 Pages: 33 - 40
Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers T. R. LesterK. K. HuntM. Z. Gilcrease Preclinical study 18 February 2011 Pages: 41 - 48
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells Aurélie CourtinLaudine CommunalAnne Gompel Preclinical study 19 February 2011 Pages: 49 - 63
FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells Juan DuLin LiJun Lu Preclinical study 05 April 2011 Pages: 65 - 73
Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint Melanie M. BadtkePurevsuren JambalBritta M. Jacobsen Preclinical study 22 February 2011 Pages: 75 - 87
Cancer predisposing BARD1 mutations in breast–ovarian cancer families Magdalena RatajskaEwelina AntoszewskaJanusz Limon Preclinical study 23 February 2011 Pages: 89 - 97
The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial Virginia P. HendersonLynn ClemowJames R. Hébert Clinical Trial 08 September 2011 Pages: 99 - 109
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer Devika GajriaJoseph GonzalezTiffany A. Traina Clinical trial 04 September 2011 Pages: 111 - 116
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques Bas B. KoolenMarie-Jeanne T. F. D. Vrancken PeetersRenato A. Valdés Olmos Clinical trial 21 September 2011 Pages: 117 - 126
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer Alain LortholaryAnne-Claire Hardy-BessardRémy Largillier Clinical trial 24 September 2011 Pages: 127 - 135
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients Kazuma KiyotaniTaisei MushirodaHitoshi Zembutsu Clinical Trial 23 September 2011 Pages: 137 - 145
A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema Sheila H. RidnerBarbara MurphyMary S. Dietrich Clinical Trial 30 September 2011 Pages: 147 - 158
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer Rulla M. TamimiGraham A. ColditzLaura C. Collins Epidemiology 10 August 2011 Pages: 159 - 167
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors Madiha F. Abdel-MaksoudBetsy C. RisendalTim E. Byers Epidemiology 06 August 2011 Pages: 169 - 176
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study Carolina EllbergHelena JernströmHåkan Olsson Epidemiology 10 August 2011 Pages: 177 - 186
Lifecourse predictors of mammographic density: the Newcastle Thousand Families cohort Study Mark S. PearcePeter W. G. TennantLouise Parker Epidemiology 11 August 2011 Pages: 187 - 195
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients Yoon Hee ChoJing ShenRegina M. Santella Epidemiology 12 August 2011 Pages: 197 - 205
Predictors of timing of adjuvant chemotherapy in older women with hormone receptor–negative, stages II–III breast cancer Stephanie B. WheelerWilliam R. CarpenterAndrea K. Biddle Epidemiology 13 August 2011 Pages: 207 - 216
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients Jae Myoung NohDoo Ho ChoiKorea Breast Cancer Study Group Epidemiology 17 August 2011 Pages: 217 - 222
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancer Tove F. TvedskovMaj-Britt JensenEva Balslev Epidemiology 18 August 2011 Pages: 223 - 229
Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999–2006 Nalini SathiakumarElizabeth DelzellMeredith L. Kilgore Epidemiology 13 August 2011 Pages: 231 - 238
Carotenoids and breast cancer risk: a meta-analysis and meta-regression Fulan HuBaina Wang YiYashuang Zhao Epidemiology 07 September 2011 Pages: 239 - 253
The vitamin D pathway and mammographic breast density among postmenopausal women Brian L. SpragueAmy Trentham-DietzHalcyon G. Skinner Epidemiology 17 August 2011 Pages: 255 - 265
Tissue composition of mammographically dense and non-dense breast tissue Karthik GhoshKathleen R. BrandtCeline M. Vachon Epidemiology 30 August 2011 Pages: 267 - 275
A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms Kathy J. HelzlsouerLisa GallicchioErrol Rushovich Epidemiology 09 September 2011 Pages: 277 - 285
Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women Roni T. FalkElisabet GentzscheinMark E. Sherman Epidemiology 26 August 2011 Pages: 287 - 294
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause Jacquie ChirgwinZhuoxin Sunfor the BIG 1-98 Collaborative and International Breast Cancer Study Groups Brief Report 04 September 2011 Pages: 295 - 306
Non-existence of caveolin-1 gene mutations in human breast cancer Neill PataniMaryou B. LambrosJorge S. Reis-Filho Brief Report 11 September 2011 Pages: 307 - 310
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival Verena VaradiMelanie BevierAsta Försti Brief Report 21 September 2011 Pages: 311 - 319
Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models Elizabeth IornsJennifer ClarkeMarc Lippman Brief Report 24 September 2011 Pages: 321 - 324
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor Sarah V. ColonnaL. Douglas CaseJulia A. Lawrence Brief Report 02 October 2011 Pages: 325 - 331
The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent Stephanie CoteSuzanna L. ArcandPatricia N. Tonin Brief Report 27 September 2011 Pages: 333 - 340
Erratum to: The BRCA2 c.9004G>A (E3002K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent Stephanie CoteSuzanna L. ArcandPatricia N. Tonin Erratum 03 November 2011 Pages: 341 - 341
Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy Bethany WilsonChristy SappSuleiman Massarweh Brief Report 26 October 2011 Pages: 343 - 346
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant Christina JustenhovenOfure ObazeeHiltrud Brauch Letter to the Editor 26 October 2011 Pages: 347 - 350
Regarding “Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients” Hiu-Fung YuenShu-Dong ZhangUi-Soon Khoo Letter to the Editor 26 October 2011 Pages: 351 - 352
Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies Su LuZhanwei WangXishan Hao Erratum 07 October 2010 Pages: 353 - 353
Erratum to: Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects Su LuZhanwei WangXishan Hao Erratum 07 October 2010 Pages: 355 - 355
